Genitourinary Cancer
News
Bladder sparing found safe for near-complete responders
Major Finding: Relative to patients having a complete response (T0) to induction chemoradiation, patients having a near-complete response (Ta/Tis...
Conference Coverage
Longer-term safety of radium-223 is reassuring
Major finding: At 1.5 years post treatment, there was a 3% incidence of myelosuppression and a single case of aplastic anemia in the radium-223...
Conference Coverage
Older men with prostate cancer have greater risk of CVD, diabetes after prolonged hormonal therapy
Major Finding: The risks of cardiovascular disease and diabetes were elevated after more than 2 years of ADT among men in their mid-70s.Data...
News
Recognizing ‘new’ type of renal carcinoma
Major Finding: The most important morphologic clue to a diagnosis of succinate dehydrogenase–deficient renal carcinoma is the presence of...
News
Poor accrual halts one in five cancer clinical trials
Major finding: About 20% of cancer clinical trials fail to reach completion for reasons unrelated to efficacy or toxicity, and the most common...
News
Test may help identify prostate cancer patients for active surveillance
Conference Coverage
Metastatic RCC patients taking common antihypertensives lived longer
Major Finding: Overall survival was 27 months among users of angiotensin system inhibitors and 17 months among nonusers (hazard ratio, 1.21; P = ....
Conference Coverage
Radiation therapy has long-term benefit in prostate cancer
Major finding: Addition of radiation therapy to lifelong antiandrogen therapy reduced 10-year prostate cancer–specific mortality from 19% to 8%....
Conference Coverage
Enzalutamide improves survival in chemo-naive metastatic prostate cancer
Major finding: Compared with placebo, enzalutamide yielded better overall survival (hazard ratio, 0.71) and radiographic progression-free survival...